Post-IPO Equity Companies in South San Francisco

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.